Resources

Past Presentation

Hepatocellular Carcinoma Surveillance in Indigenous Communities: Are we doing enough? | March 28, 2023

Date of Presentation: March 28, 2023

Type: Past Presentation  

Audience: Clinical  Community  

Program: Grand Rounds  

Keywords: #express  #grand rounds  #sti  #testing  

In this series of presentations, Dr. Brian McMahon, Hepatologist at the Alaska Native Tribal Health Consortium, discusses the epidomology, surveillance, and management of patients with Hepatocellular Carcinoma (HCC) in Indigenous communities. Dr. McMahon also describes who’s at risk for developing HCC, the incidence for HCC, how we identify persons with cirrhosis, who we should evaluate, screening methodologies, and what we can do to improve early detection of liver fibrosis in our communities at risk for HCC.

The one-hour Grand Rounds session included an opportunity to engage in a didactic presentation, gain insight on how I/T/U facilities may effectively implement HCC screening, become part of a learning community, and join a Hepatitis C ECHO program.

Recording:

Presented by:

Brian J McMahon, MD

Brian J. McMahon, MD, is a clinical Hepatologist and the Director of the Liver Disease and Hepatitis Program at the Alaska Native Medical Center in Anchorage, Alaska, and guest researcher at the Arctic Investigations Program of the CDC in Anchorage. He is a fellow in the AASLD and a Master in the American College of Physicians. His program follows over 1200 Alaska Native Persons with chronic hepatitis B and 2400 with chronic hepatitis C throughout Alaska. The hepatitis B program has already met the all WHO 2030 goals for HBV. He conducts research on long-term outcome and management of chronic hepatitis B and C. He was involved in the previous World Indigenous Peoples’ Conference on Viral Hepatitis events, sits on the organizing committee and brings expertise in how viral hepatitis impacts Alaska Natives and American Indians.

Resources Provided:

Date added: February 24, 2023